His main research concerns Immunology, Melanoma, Antigen, Antibody and Immune system. His research in Immunology tackles topics such as Cytotoxic T cell which are related to areas like Tumor microenvironment. His Melanoma research incorporates themes from Stage, Internal medicine, Clinical trial and Pathology.
His Pathology research is multidisciplinary, relying on both Cancer and Gene expression profiling. His Antigen study combines topics from a wide range of disciplines, such as Pan-T antigens and Antigen presentation. His work on Monoclonal antibody, Monoclonal and Immunoglobulin G as part of general Antibody study is frequently connected to Melanocyte differentiation, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
The scientist’s investigation covers issues in Immunology, Antigen, Melanoma, Immune system and Antibody. In Immunology, Alan N. Houghton works on issues like Cytotoxic T cell, which are connected to Tumor microenvironment. His Antigen study incorporates themes from Monoclonal antibody and Virology.
His Melanoma research integrates issues from Cancer, Internal medicine and Pathology. His work deals with themes such as Cancer cell and Tumor progression, which intersect with Immune system. Alan N. Houghton has researched T cell in several fields, including Cellular immunity and Cell biology.
Alan N. Houghton mainly focuses on Immunology, Immune system, Antigen, Melanoma and Cytotoxic T cell. CD8, T cell, Immunotherapy, DNA vaccination and IL-2 receptor are subfields of Immunology in which his conducts study. His Immune system research includes themes of Adjuvant, Stimulation and Virology.
His research in Antigen intersects with topics in Antibody, Monoclonal antibody and Autoimmunity. His Melanoma research is multidisciplinary, incorporating elements of Internal medicine, Null cell and Active immunization. His Cytotoxic T cell research includes themes of Tumor microenvironment, Acquired immune system and Cancer research.
Alan N. Houghton focuses on Immunology, Cytotoxic T cell, Immune system, CD8 and Antigen. His Immunology study frequently links to other fields, such as Melanoma. His Melanoma research focuses on Internal medicine and how it connects with Oncology.
His study looks at the relationship between Cytotoxic T cell and fields such as Tumor microenvironment, as well as how they intersect with chemical problems. His research investigates the connection between CD8 and topics such as FOXP3 that intersect with issues in Regulatory T cell and Glucocorticoid-Induced TNFR-Related Protein. Antigen and Antibody are commonly linked in his work.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma
Charles M. Balch;Antonio C. Buzaid;Seng-Jaw Soong;Michael B. Atkins.
Journal of Clinical Oncology (2001)
Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma.
Alan N. Houghton;David Mintzer;Carlos Cordon-Cardo;Sydney Welt.
Proceedings of the National Academy of Sciences of the United States of America (1985)
Generation of human monoclonal antibodies reactive with cellular antigens
Richard J. Cote;Donna M. Morrissey;Alan N. Houghton;Edward J. Beattie.
Proceedings of the National Academy of Sciences of the United States of America (1983)
Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells.
Mary Jo Turk;José A. Guevara-Patiño;Gabrielle A. Rizzuto;Manuel E. Engelhorn.
Journal of Experimental Medicine (2004)
Fc receptors are required in passive and active immunity to melanoma
Raphael Clynes;Yoshizumi Takechi;Yoichi Moroi;Alan Houghton.
Proceedings of the National Academy of Sciences of the United States of America (1998)
Diagnosis and Treatment of Early Melanoma: NIH Consensus Development Panel on Early Melanoma
Lowell A. Goldsmith;Frederic B. Askin;Alfred E. Chang;Cynthia Cohen.
Focus on melanoma
Alan N Houghton;David Polsky.
Cancer Cell (2002)
Receptor-Mediated Uptake of Antigen/Heat Shock Protein Complexes Results in Major Histocompatibility Complex Class I Antigen Presentation via Two Distinct Processing Pathways
Flora Castellino;Philip E. Boucher;Katrin Eichelberg;Mark Mayhew.
Journal of Experimental Medicine (2000)
An Evidence‐based Staging System for Cutaneous Melanoma
Charles M. Balch;Seng Jaw Soong;Michael B. Atkins;Antonio C. Buzaid.
CA: A Cancer Journal for Clinicians (2004)
A new American Joint Committee on Cancer staging system for cutaneous melanoma.
Charles M. Balch;Antonio C. Buzaid;Michael B. Atkins;Natale Cascinelli.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: